Search Results

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

• Authors : van der Wouden, CH; Cambon‐Thomsen, A; Cecchin, E

Subjects: PHARMACOGENOMICS; INDIVIDUALIZED medicine; COMPANION diagnostics

• Source: Clinical Pharmacology & Therapeutics; Mar2017, Vol. 101 Issue 3, p341-358, 18p

Record details

Measuring the Value of Pharmacogenomics Evidence.

• Authors : Patrinos, GP; Mitropoulou, C

Subjects: PHARMACOGENOMICS; WARFARIN; DRUG therapy

• Source: Clinical Pharmacology & Therapeutics; Nov2017, Vol. 102 Issue 5, p739-741, 3p

Record details

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

• Authors : van der Wouden, CH; Cambon‐Thomsen, A; Cecchin, E

Subjects: PHARMACOGENOMICS; CONSORTIA

• Source: Clinical Pharmacology & Therapeutics; Jul2017, Vol. 102 Issue 1, p152-152, 1p

Record details

Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets.

• Authors : Pisanu C; Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy. .; Congiu D

Subjects: Cellular Senescence*/Cellular Senescence*/Cellular Senescence*/genetics ; Genetic Pleiotropy* ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/genetics

• Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 May; Vol. 49 (6), pp. 1033-1041. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students.

• Authors : Al-Suhail H; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Omar M

• Source: Frontiers in pharmacology [Front Pharmacol] 2024 Apr 11; Vol. 15, pp. 1377420. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

How Can We Boost the Pharmacogenomics Adoption Rate in Clinical Practice Around the World?

• Authors : Vasileiou KZ; Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, School of Health Sciences, Patras, Greece.; Patrinos GP

Subjects: Pharmacogenetics*/Pharmacogenetics*/Pharmacogenetics*/methods; Humans ; Precision Medicine/Precision Medicine/Precision Medicine/methods

• Source: Omics : a journal of integrative biology [OMICS] 2024 Apr; Vol. 28 (4), pp. 204-205. Date of Electronic Publication: 2024 Apr 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity.

• Authors : Ferous S; Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.; Siafakas N

• Source: Journal of personalized medicine [J Pers Med] 2024 Mar 26; Vol. 14 (4). Date of Electronic Publication: 2024 Mar 26.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426

Record details

Clinical implementation of preemptive pharmacogenomics in psychiatry.

• Authors : Skokou M; Karamperis K ...

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/drug therapy ; Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/genetics ; Psychiatry*

• Source: EBioMedicine [EBioMedicine] 2024 Mar; Vol. 101, pp. 105009. Date of Electronic Publication: 2024 Feb 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients.

• Authors : Ivantsik O; Laboratory of Pharmacogenomics and Individualized Therapy, Division of Pharmacology and Biosciences, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Rion, Greece.; John A

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/pathology; Humans ; Mutation Amyotrophic lateral sclerosis 1

• Source: Genes [Genes (Basel)] 2024 Feb 28; Vol. 15 (3). Date of Electronic Publication: 2024 Feb 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425

Record details

Fine-mapping genomic loci refines bipolar disorder risk genes.

• Authors : Koromina M; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

• Source: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Feb 13. Date of Electronic Publication: 2024 Feb 13.Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not

Record details